1. Home
  2. NERV vs TONX Comparison

NERV vs TONX Comparison

Compare NERV & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

N/A

Current Price

$4.43

Market Cap

231.1M

Sector

Health Care

ML Signal

N/A

Logo TON Strategy Company

TONX

TON Strategy Company

HOLD

Current Price

$3.32

Market Cap

187.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NERV
TONX
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
231.1M
187.2M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
NERV
TONX
Price
$4.43
$3.32
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.50
N/A
AVG Volume (30 Days)
132.9K
391.5K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.21
EPS
N/A
N/A
Revenue
$41,175,600.00
$32,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
433.33
52 Week Low
$1.93
$1.75
52 Week High
$12.46
$8.23

Technical Indicators

Market Signals
Indicator
NERV
TONX
Relative Strength Index (RSI) 49.84 57.42
Support Level $3.87 $3.02
Resistance Level $4.73 $3.54
Average True Range (ATR) 0.33 0.26
MACD -0.03 0.05
Stochastic Oscillator 19.49 83.00

Price Performance

Historical Comparison
NERV
TONX

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

Share on Social Networks: